Claims for Patent: 8,057,998

Summary for Patent: 8,057,998

Title:	Isolated genomic polynucleotide fragments from chromosome 19 that encode human syntaxin
Abstract:	The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human resistin and human syntaxin binding protein 2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s):	Ryan; James W (Augusta, GA)
Assignee:	Ryogen LLC (Suffern, NY)
Application Number:	12/276,550
Patent Claims:	1. An isolated genomic nucleic acid molecule, said nucleic acid molecule selected from the group consisting of: (a) a nucleic acid molecule consisting of a nucleic acid sequence which has at least 99% identity to the nucleic acid molecule of SEQ ID NO:4 and which encodes a polypeptide having the amino acid sequence of SEQ ID NO:2, wherein said polypeptide binds to syntaxins 1A, 2 and 3 but not to syntaxin 4; (b) a fragment of the nucleic acid molecule of (a), said fragment comprising at least nucleotides 8391-19051 of SEQ ID NO:4 and which encodes a polypeptide having the amino acid sequence of SEQ ID NO:2, wherein said polypeptide binds to syntaxins 1A, 2 and 3 but not to syntaxin 4, and; (c) a full complement of (a) or (b) in a sample. 2. A nucleic acid construct comprising the nucleic acid molecule of claim 1. 3. A composition comprising the nucleic acid molecule of claim 1 and a carrier. 4. An isolated nucleic acid molecule consisting of a sequence segment of a nucleic acid molecule of claim 1, wherein said segment is 60-750 nucleotides in length consisting of a contiguous coding and non-coding nucleic acid sequence of SEQ ID NO:4 or a full complement of said isolated nucleic acid molecule. 5. A kit comprising the nucleic acid molecule of claim 1. 6. The kit according to claim 5, in which the nucleic acid molecule is labeled with a detectable substance. 7. A kit comprising the nucleic acid molecule of claim 4. 8. The kit according to claim 7, in which the nucleic acid molecule is labeled with a detectable substance. 9. A microarray comprising one or more of the nucleic acid molecules of claim 1. 10. A kit comprising the microarray of claim 9. 11. A microarray comprising one or more of the nucleic acid molecules of claim 4. 12. A kit comprising the microarray of claim 11. 13. An expression vector comprising the nucleic acid molecule of claim 1. 14. A recombinant host cell comprising the nucleic acid molecule of claim 1. 15. A method for obtaining a polypeptide having human syntaxin binding protein 2 activity comprising: (a) culturing the recombinant host cell of claim 14 under conditions that provide for the expression of said polypeptide and (b) recovering said expressed polypeptide. 16. A method of detecting the presence of a nucleic acid sequence of SEQ ID NO:4, its complementary sequence or unique fragment thereof in a sample, said method comprising contacting the sample with the nucleic acid molecule of claim 1 and determining whether the nucleic acid molecule binds to said nucleic acid sequence in the sample. 17. A method of identifying a nucleotide sequence variant of a 5'-noncoding region, 3'-noncoding region or intron region of SEQ ID NO:4 or its complementary sequence comprising (a) isolating genomic DNA from a sample and (b) determining the presence or absence of a nucleotide sequence variation in said genomic DNA by comparing the nucleotide sequence of SEQ ID NO:4 with the nucleotide sequence of the isolated genomic DNA and establishing if and where a difference occurs between the two nucleic acid sequences thereby identifying a nucleotide sequence variant of SEQ ID NO:4 or its complement. 18. The method according to claim 17, wherein said variant encodes a protein having human syntaxin 2 activity. 19. A method for detecting the presence of the nucleic acid molecule of claim 1 in a sample, comprising contacting the sample with a polynucleotide probe comprising at least 20 contiguous nucleotides that hybridizes to said nucleic acid molecule under stringent conditions and determining whether the polynucleotide probe binds to said nucleic acid molecule in the sample.

Details for Patent 8,057,998

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2025-07-09
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2025-07-09
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2025-07-09